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Part I: Recommendations for Immunization Procedures
The purpose o f these recommendations is to provide in form ation on rabies vaccines to 
practicing veterinarians, public health officials, and others concerned w ith  rabies control. This 
document w ill serve as the basis fo r anim al rabies vaccination programs throughout the 
United States. Its adoption by cooperating organizations w ill resu lt in standardization o f proce­
dures among jurisdictions, which is necessary fo r an effective national rabies control program. 
These recommendations are reviewed and revised as necessary before the beginning o f each 
calendar year. A ll animal rabies vaccines licensed by the United States Department o f Agricul­
ture (USDA) and m arketed in the United States are lis ted in Part II o f  the Compendium, and 
Part III describes the principles o f rabies control.
A. VACCINE ADMINISTRATION: The Committee recommends that all animal rabies vaccines 
be restricted to use by or under the supervision of a veterinarian.
B. VACCINE SELECTION: While recognizing the efficacy of vaccines providing one-year dura­
tion of immunity, the Committee recommends the use of vaccines providing three-year du­
ration of immunity because their use constitutes the most effective method of increasing 
the proportion of immunized dogs and cats in comprehensive rabies control programs.
C. ROUTE OF INOCULATION: All rabies vaccines must be administered intramuscularly at 
one site in the thigh.
D. HIGH-RISK RABIES AREA: An area (town, city, or county) where a high incidence of rabies 
exists among wildlife or domestic species, as determined by state health officials, may be 
declared a High Risk Rabies Area. In such areas, the public should be alerted to the risk and 
urged to make sure that their dogs and cats have current rabies vaccinations. State health 
officials may wish to consider temporarily altering revaccination schedules.
E. WILDLIFE VACCINATION: The Committee recommends that neither wild nor exotic ani­
mals be kept as pets. Since no rabies vaccine is licensed for use in wild animals and since 
there is no evidence that animal rabies vaccines produce acceptable levels of immunity in 
wild animals, vaccination is not recommended.
F. ACCIDENTAL HUMAN EXPOSURE TO VACCINE: Accidental human inoculation may occur 
during administration of animal rabies vaccine. Such exposures to inactivated vaccines 
constitute no known rabies hazard. No cases of human rabies have resulted from needle 
or other exposure to a licensed modified live virus vaccine in the United States.
G. IDENTIFICATION OF VACCINATED DOGS: The Committee recommends that all govern­
ment agencies and veterinarians adopt the standard tag system. This will aid the adminis­
tration of local, state, national, and international procedures. Dog license tags should not 
conflict in shape and color with rabies tags.
U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES / PUBLIC HEALTH SERVICE
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1. Rabies Tags:
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2. Rabies Certificate: Government agencies and veterinarians should use the NASPHV 
form #50, Rabies Vaccination Certificate, which can be obtained from vaccine manufac­
turers.
Part II: Vaccines Marketed in United States and 
NASPHV Recommendations
Age at
Product name For use primary Booster
Vaccine: generic name Produced by Marketed by In* Dosage^ vaccination § recommended
A) MODIFIED LIVE VIRUS
Canine cell line origin NORDEN ENDURALL-R 3 mos &
License No. 189 Norden Dogs 1 ml 1 yr later Triennially
High egg passage Cats 1 ml 3 months Annually
Dogs 1 ml 3 mos &
1 yr later Triennially
WELLCOME ERA STRAIN Cattle 1 ml 4 months Annually
Porcine cell line origin (Jensen-Salsbery) RABIES VACCINE Horses 1 ml 4 months Annually
License No. 107 Wellcome
High cell passage (Jensen-Salsbery) Sheep 1 ml 4 months Annually
Goats 1 ml 4 months Annually
Canine tissue culture PHILIPS NEUROGEN-TC 3 mos &
origin ROXANE Bio-Ceutic Dogs 1 ml 1 yrlater Triennially
High cell passage License No. 124
Canine tissue culture PHILIPS UNIRAB
origin ROXANE Bio-Ceutic Dogs 1 ml 3 months Annually
High cell passage License No. 124
B) INACTIVATED
Murine origin ROLYNN TRIMUNE 3 mos &
License No. 165-B Ft. Dodge Dogs 1 ml 1 yr later Triennially
(Prev. No. 266) Cats 1 ml 3 months Annually
Murine origin ROLYNN ANNUMUNE Dogs 1 ml 3 months Annually
License No. 165-B Ft. Dodge Cats 1 ml 3 months Annually
(Prev. No. 266)
Murine origin DOUGLAS BIORAB-1 Dogs 1 ml 3 months Annually
License No. 165-B Cats 1 ml 3 months Annually
(Prev. No. 266)
3 mos &
Murine origin DOUGLAS BIORAB-3 Dogs 1 ml 1 yr later Triennially
License No. 165-B Cats 1 ml 3 months Annually
(Prev. No. 266)
WILDLIFE
Murine origin VACCINES, INC. DURA-RAB 1 Dogs 1 ml 3 months Annually
License No. 277 Wildlife vaccines Cats 1 ml 3 months Annually
Hamster cell line origin BEECHAM RABCINE Dogs 1 ml 3 months Annually
License No. 225 Beecham Cats 1 ml 3 months Annually
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V a c c in e : ge n e ric  n a m e Prod uced  b y
P rod uct n a m e  
M a r k e te d  b y
For use  
in * D o s a g e ‘t'
A ge a t  
p rim a ry
v a c c in a tio n  ̂
B o o ster
re c o m m e n d e d
B) INACTIVATED
Hamster cell line origin BEECHAM RABCINE-FELINE
License No. 225 Beecham Cats 1 ml 3 months Annually
Hamster cell line origin VACCINES, INC. RABIES VACC. Dogs 1 ml 3 months Annually
License No. 227 Guardian
Hamster cell line origin JACKSON RABMUNE Dogs 1 ml 3 months Annually
License No. 288 Schering Cats 1 ml 3 months Annually
Porcine cell line origin NORDEN ENDURALL-K Dogs 1 ml 3 months Annually
License No. 189 Norden Cats 1 ml 3 months Annually
—
3 mos &
Porcine cell line origin NORDEN RABGUARD-TC Dogs 1 ml 1 yr later Triennially
License No. 189 Norden Cats 1 ml 3 mos &
1 yr later Triennially
Monkey cell line origin WELLCOME CYTORAB Dogs 1 ml 3 months Annually
License No. 107 Wellcome Cats 1 ml 3 months Annually
3 mos &
Monkey cell line origin WELLCOME TRIRAB Dogs 1 ml 1 yr later Triennially
License No. 107 Wellcome Cats 1 ml 3 months Annually
Feline cell line origin FROMM RABVAC Dogs 1 ml 3 months Annually
License No. 195-A Fromm Cats 1 ml 3 months Annually
C) COMBINATION
Murine origin DOUGLAS 




Cats 1 ml 3 months Annually
Feline cell line origin FROMM
License No. 195-A
ECLIPSE III KP-R 
Fromm
Cats 1 ml 3 months Annually




Cats 1 ml 3 months Annually
‘Refers only to domestic species of this class of animals.
^All vaccines must be administered intramuscularly at one site in the thigh.
^Three months is the earliest age recommended. Dogs and cats vaccinated between 3 and 12 months should be 
revaccinated 1 year later.
Part III: Principles of Rabies Control
These guidelines have been prepared by the National Association o f State Public Health Veter­
inarians (NASPHV) fo r use by government officia ls, practicing veterinarians, and others who 
m ay become involved in certain aspects o f  rabies control. The NASPHV plans to annually 
review  and revise these recommendations as necessary. Standardized contro l procedures are 
needed to e ffective ly  deal w ith  the public health aspects o f rabies.
A. PRINCIPLES OF RABIES CONTROL
1. The Disease in Humans: Rabies in humans can be prevented by eliminating exposure 
to rabid animals and by prompt locai wound treatment and immunization when
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exposed. Current recommendations of the Public Health Service Immunization Practices
Advisory Committee (ACIP) are suggested for consideration by attending physicians. 
The recommendations along with the current status of animal rabies in the region and 
information concerning the availability of rabies biologies are available from state 
health departments.
2. Domestic Anim als: Local governments should initiate and maintain effective programs 
to remove strays and unwanted animals and ensure vaccination of all dogs and cats. 
Since cat rabies cases now equal the annual incidence in dogs, immunization of cats 
should be emphasized. Such procedures in the United States have reduced laboratory- 
confirmed rabies cases in dogs from 8,000 in 1947 to 216 in 1981. The recommended 
vaccination procedures and the licensed animal vaccines are specified in Parts I and II of 
the NASPHV's annually released Compendium.
3. Rabies in W ild life: The control of rabies in foxes, skunks, raccoons, and other terrestri­
al animals is very difficult. Selective reduction of these populations when indicated may 
be useful, but the utility of this procedure depends heavily on the circumstances sur­
rounding each rabies outbreak.
B. CONTROL METHODS IN DOMESTIC AND CONFINED ANIMALS
1. Pre-Exposure Vaccination and Management
Animal rabies vaccines, because of species limitations, techniques, and tolerances, 
should be administered only by or under the direct supervision of a veterinarian. Within 
one month after vaccination, a peak rabies antibody titer is reached, and the animal can 
be considered to be immunized (see Parts I and II of the Compendium for recommended 
vaccines and procedures). (Continued on page 693)
TABLE I. Summary—cases of specified notifiable diseases. United States
51 st Week Ending Cumulative, First 51 Weeks












Aseptic meningitis 169 93 93 9,040 9,358 7,682
Brucellosis 3 6 6 154 179 179
Encephalitis: Primary (arthropod-borne 
& unspec) 2 2 2 2 2 0 1,427 1,500 1,163
Post-infectious - 1 1 62 79 2 1 0
Gonorrhea: Civilian 16,827 14,432 16,880 936,927 978,492 983,104
Millitary 139 462 424 25,057 27,711 26,230
Hepatitis: Type A 348 453 542 22,300 25,034 28,670
Type B 364 378 366 21,155 20,466 16,131
Non A, Non B 43 N N 2,335 N N
Unspecified 162 179 179 8,638 10,691 10,345
Legionellosis 11 N N 550 N N
Leprosy 3 2 2 224 238 173
Malaria 6 9 12 1,001 1,324 807
Measles (rubeola) 39 11 134 1,687 2,957 13,449
Meningococcal infections: Total 46 64 60 2,856 3,436 2,542
Civilian 46 64 60 2,843 3,423 2,522
Military - - - 13 13 19
Mumps 57 151 292 5,117 4,721 13,681
Pertussis 58 17 34 1,739 1,225 1,636
Rubella (German measles) 2 2 37 104 2,263 2,058 11,633
Syphilis (Primary & Secondary): Civilian 470 412 455 32,107 30,435 24,590
Military - 3 7 427 360 313
Tuberculosis 481 422 582 25,261 26,660 27,210
Tularemia 3 2 2 247 278 190
Typhoid fever 7 14 7 398 573 513
Typhus fever, tick-borne (RMSF) 4 2 5 981 1,181 1,118
Rabies, animal 48 60 60 5,946 6,992 4,875






Botulism (Mass. 1, Wash. 1) 78 Paralytic 7
Cholera - Psittacosis 116
Congenital rubella syndrome (Ariz. 1) 7 Rabies, human
Diphtheria 3 Tetanus 79
Leptospirosis (Oreg. 1) 73 Trichinosis (Mass. 1) 84
Plague 18 , Typhus fever, flea-borne (endemic, murine) (Tex. 2) 45
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TABLE III.  Cases of specified notifiable diseases, United States, weeks ending























Hepatitis (Viral), by type
B NA.NB U"sp®ci tied







UNITED STATES 169 154 1,427 62 936,927 978,492 348 364 43 162 11 224
NEW ENGLAND 4 3 56 6 22,660 23,710 7 24 . 14 1 2
Maine - - - - 1,193 1,286 . . .
N.H. - - 8 - 721 874 1 1 _
Vt. - - - 416 422 2 .
Mass. 2 - 26 - 10,143 10,087 2 8 _ 13 .
R.l. 2 - - 1 1,542 1,469 1 2 . _ _
Conn. 3 2 2 5 8,645 9,572 2 13 - 1 2
MID ATLANTIC 13 3 151 14 119,676 117,308 40 67 2 2 0 31
Upstate N Y. 7 3 62 3 19,873 20,879 7 17 1 3 . 3
N Y. City 2 - 21 - 48,939 47,437 17 33 . 7 - 26
N.J. 3 - 24 - 21,815 22,207 4 5 1 5 1
Pa 1 * 44 11 29,049 26,785 12 12 - 5 1
E.N. CENTRAL 21 7 355 12 130,427 146,592 34 32 5 13 4 10
Ohio 9 1 140 5 35,376 45,494 11 9 1 5 1 .
Ind U - 95 3 15,738 12,489 U U U U U
III. 5 18 2 34,829 43,289 16 12 4 3 8
Mich. 12 1 73 32,597 32,179 7 11 . 5 3
Wis. - - 29 2 11,887 13,141 - - - - 2
W.N. CENTRAL 7 17 101 4 43,829 46,685 6 6 1 2 8
Minn U 1 27 1 6,305 7,406 U U U U U 4
Iowa - 5 54 1 4,780 5,095 1 1
Mo 2 4 9 - 20,737 21,692 1 1 1 . . 2
N Dak - 1 - - 562 594 . _ .
S. Dak 1 - 1 1,103 1,249 _ 1
Nebr - 2 6 - 2,602 3,459 1 . 1
Kans 5 3 5 1 7,740 7,190 5 3 - 1 -
S. ATLANTIC 31 30 2 0 2 9 244,138 241,330 27 90 12 17 4 1 1
Del - - 4,089 3,872 1
Md 1 - 25 30,829 28,797 1 2 2 1 1 1 4
DC. - - 14,987 13,596 .
Va 2 10 44 1 19,674 21,970 4 10 2 1 2 1
W . Va 1 16 - 2,739 3,505 . 2
N.C. 6 - 31 1 38,767 37,015 1 6 . 1 _
S.C. 1 2 2 23,820 23,378 10 11 3 . .
Ga 1 4 14 48,024 49,812 2 10 1 1 _ 1
Fla. 19 14 70 7 61,209 59,385 9 29 5 12 1 5
E.S CENTRAL 7 14 6 8 6 81,707 81,730 38 23 1 4 .
Ky. - - 1 - 10,802 10,228 1 . . 2
Tenn 5 9 31 1 32,100 31,194 13 17 1 1 - .
Ala - 4 18 5 24,401 24,478 21 4 . 1 _
Miss. 2 1 18 - 14,404 15,830 3 2 - -
W.S CENTRAL 34 45 226 1 130,523 128,582 69 36 . 52 29Ark - 7 21 10,323 9,822 2 1 - 7
La 2 8 29 24,279 22,892 8 13 . . _
Okla. 5 8 40 14,353 14,046 6 2 1 _
Tex. 27 22 136 1 81,568 81,822 53 2 0 44 - 29
MOUNTAIN 11 3 57 2 31,465 38,693 33 22 5 13 2 2Mont - 2 - - 1,307 1,409 .
Idaho 3 1 - 1,493 1,704 . 1 . _ 1
Wyo. - 1 952 1,017 _ _ . _
Colo 6 - 2 0 1 8,445 10,309 6 5 2 2 1N. Mex. 1 4,328 4,385 7 .







































































N: Not notifiable U: Unavailable
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TABLE III.  (Cont.'d). Cases of specified notifiable diseases, United States, weeks ending
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TABLE III.  (Cont.'d). Cases of specified notifiable diseases, United States, weeks ending
December 25, 1982 and December 26, 1981 (51st week)
Reporting Area
Syphilis (Civilian) 
























UNITED STATES 32,107 30,435 481 25,261 247 7 398 4 981 5,946
NEW ENGLAND 603 586 19 736 7 18 12 42Maine 8 5 1 55 . . . 26
1N.H. 5 16 30 _ . 1
Vt. 7 17 1 12 _ . 2 2
Mass. 405 373 12 465 7 . 14 _ 6 7R.l. 27 35 - 36 . 2
Conn. 151 140 5 138 - - 2 - 3 6
MID. ATLANTIC 4,339 4,351 79 4,229 7 69 45 2 0 2Upstate N Y. 433 439 4 726 7 . 12 16 1 1 2N Y. City 2,558 2,585 24 1,592 _ . 36 3N.J. 640 608 24 834 _ . 13 14 17Pa. 708 719 27 1,077 - - 8 - 12 73
E.N. CENTRAL 1,810 2,333 42 3,742 1 1 38 8 8 590Ohio 333 319 4 597 13 . 77 80Ind. 195 313 U 451 _ U 2 U 2 73III. 902 1,250 31 1,628 8 8 299Mich. 279 360 7 855 . 1 12 7
Wis. 101 91 2 11 1 3 - 1 131
W.N. CENTRAL 535 664 7 756 40 17 34 1,180Minn. 142 186 U 141 u 8 u 209Iowa 34 29 - 73 3 . 1 4 384Mo. 281 390 5 369 27 _ 5 . 13 1 22N. Dak. 7 12 - 15 _ . 97S. Dak. 2 2 - 33 1 _ . . 4 101Nebr. 15 11 2 32 4 . 2 . 2 123Kans. 54 34 * 93 5 - 1 - 11 144
S. ATLANTIC 8,692 8,031 71 5,256 13 48 1 522 1,264Del. 25 16 2 49 _ . 2Md. 490 563 15 619 1 _ 10 _ 50 92DC. 472 645 2 248 . .
Va. 599 685 11 595 5 . 4 . 74 707W. Va. 30 32 2 154 . 4 8 54N.C. 712 630 12 787 . 3 1 225 65s.c. 560 557 - 514 6 . 3 106 6 6Ga. 1,775 1,936 8 856 . 3 . 52 2 1 0Fla. 4,029 2,967 19 1,434 1 21 - 7 6 8
E.S. CENTRAL 2,243 1,992 35 2,305 8 2 2 2 1 98
1
638Ky. 133 107 9 604 . . 4 132Tenn. 645 672 7 757 6 1 5 . 59 354Ala. 835 615 10 618 . 1 10 1 18 145Miss. 630 598 9 326 2 3 2 0 7
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TABLE IV . Deaths in 121 U.S. cities,* *week ending 
December 25, 1982 (51st week)
All Causes, By Age (Years) All Causes, By Age (Years)
Reporting Area All





Ages 2=65 45-64 25-44 1-24 <1
NEW ENGLAND 567 363
Boston, Mass. 166 100
Bridgeport, Conn. 48 32
Cambridge, Mass 25 22
Fall River, Mass. 25 16
Hartford, Conn. 39 27
Lowell, Mass. 26 19
Lynn, Mass. 16 10
New Bedford, Mass 25 17
New Haven, Conn. 32 16
Providence, R.l. 46 25
Somerville, Mass. 14 13
Springfield, Mass. 40 26
Waterbury, Conn. 19 15
Worcester, Mass. 46 25
MID. ATLANTIC 2,694 1,810
Albany, N Y. 63 42
Allentown, Pa. § 19 19
Buffalo, N Y. 119 75
Camden, N.J. 35 27
Elizabeth, N.J. 35 26
Erie, Pa t 49 39
Jersey City, N.J. 34 24
N Y. City, N Y. 1,527 1,018
Newark, N.J. 66 41
Paterson, N.J. 28 17
Philadelphia, Pa t 325 208
Pittsburgh, Pat 69 44
Reading, Pa. 22 17
Rochester, N Y. 118 80
Schenectady, N Y. 19 16
Scranton, Pa t 25 20
Syracuse, N Y 54 33
Trenton, N.J. 40 27
Utica, N Y. 21 16
Yonkers, N Y. 26 21
E.N. CENTRAL 2,048 1,390
Akron, Ohio 70 49
Canton, Ohio 25 19
Chicago, III 483 279
Cincinnati, Ohio 137 95
Cleveland, Ohio 134 79
Columbus, Ohio 136 85
Dayton, Ohio 86 54
Detroit, Mich. § 258 234
Evansville, Ind. 32 24
Fort Wayne, Ind. 46 31
Gary, Ind. 25 12
Grand Rapids, Mich 69 50
Indianapolis, Ind. 161 92
Madison, Wis 33 21
Milwaukee, Wis 124 95
Peoria, III. 34 28
Rockford, III. 29 22
South Bend, Ind 37 22
Toledo, Ohio 88 69
Youngstown, Ohio 41 30
W.N. CENTRAL 672 451
Des Moines, Iowa 54 33
Duluth, Minn. 6 4
Kansas City, Kans. 35 23
Kansas City, Mo. 119 79
Lincoln, Nebr. 29 21
Minneapolis, Minn 86 59
Omaha, Nebr. 72 35
St. Louis, Mo. 161 120
St. Paul, Minn 53 39
Wichita, Kans 57 38
147 33 11 13 34
40 14 3 9 19
13 3 - - 4
2 1 - . .
9 - . . .
9 1 1 1 1
7 - - . 1
4 - 2 .
6 1 1 . _
10 5 1 _ .
15
i
4 1 1 2
1
9 3 1 1 2
4 - - . 1
18 1 1 1 4
601 154 75 54 115
13 3 3 2 -
35 5 2 2 9
5 2 - 1
7 2 . . .
9 1 . 1
6 - 2 2 1
334 96 43 36 53
15 8 1 1 4
7 - 3 1 3
89 22 2 4 26
18 2 4 1 5
4 - 1 . 2
21 5 9 3 7
1 - 2 . 1
3 2 . 1
17 2 2 _
10 1 1 1 .
4 1 - 2
3 2 - - -
413 106 55 80 58
16 3 1 1 1
6 . - _ 1
125 35 19 25 8
30 6 6 . 9
40 7 3 5 2
32 10 2 7 8
19 6 2 5 2
1 6 6 7 5
6 1 1 . 1
9 2 3 1 3
9 2 1 1 1
12 5 - 2 3
48 5 5 11 3
7 2 1 2 .
17 3 3 6 2
3 1 - 2 5
6 1 - - 2
10 4 1 . .
10 3 1 5 2
7 4 - - -
157 29 19 16 29
16 4 1 - 10
2 - . - 1
9 2 - 1 -
32 4 3 1 4
4 2 - 2 -
15 4 3 5 2
28 2 3 4 6
24 8 7 2 4
12 2 . -
15 1 2 1 2
S. ATLANTIC 1,235 744
Atlanta, Ga. 149 88
Baltimore, Md. 337 204
Charlotte, N.C. 57 29
Jacksonville, Fla. 64 44
Miami, Fla. 100 59
Norfolk, Va. 42 24
Richmond, Va. 82 52
Savannah, Ga. 34 22
St. Petersburg, Fla. 71 59
Tampa, Fla. 62 36
Washington, D C. 169 92
Wilmington, Del. 68 35
E.S. CENTRAL 543 354
Birmingham, Ala. 106 72
Chattanooga, Tenn. 48 33
Knoxville, Tenn. 18 14
Louisville, Ky. 100 70
Memphis, Tenn. 106 61
Mobile, Ala. 33 24
Montgomery, Ala. 21 16
Nashville, Tenn. 111 64
W.S. CENTRAL 1,097 633
Austin, Tex. 46 32
Baton Rouge, La. 41 23
Corpus Christi, Tex. 51 33
Dallas, Tex. 208 117
El Paso, Tex. 39 28
Fort Worth, Tex 79 47
Houston, Tex. 200 86
Little Rock, Ark. 39 24
New Orleans, La. 145 82
San Antonio, Tex. 151 96
Shreveport, La. 28 20
Tulsa, Okla. 70 45
MOUNTAIN 512 314
Albuquerque, N.Mex 37 28
Colo. Springs, Colo. 32 19
Denver, Colo. 103 48
Las Vegas, Nev. 71 44
Ogden, Utah 15 12
Phoenix, Ariz 116 73
Pueblo, Colo. 24 16
Salt Lake City, Utah 47 25
Tucson, Ariz. 67 49
PACIFIC 1,831 1,245
Berkeley, Calif. 21 15
Fresno, Calif. 98 76
Glendale, Calif. 22 14
Honolulu, Hawaii 65 41
Long Beach, Calif. 104 74
Los Angeles, Calif 567 370
Oakland, Calif. § 62 58
Pasadena, Calif 29 22
Portland, Oreg. 106 72
Sacramento, Calif § 70 64
San Diego, Calif. 92 59
San Francisco, Calif. 185 109
San Jose, Calif. 164 105
Seattle, Wash. 149 101
Spokane, Wash. 62 39
Tacoma, Wash. 35 26
TOTAL 11,199++ 7,304
319 98 44 30 48
36 18 5 2 6
96 23 8 6 11
15 6 4 3 2
13 4 2 1 2
30 7 4 - .
9 2 4 3 4
22 4 2 2 10
8 2 1 1 3
8 1 2 1 2
10 5 4 7 4
51 19 4 3 2
21 7 4 1 2
127 24 15 23 28
20 5 3 6 4
11 1 2 1 3
2 1 1 2
22 4 2 2 9
28 3 - 14 5
7 2 - - 1
3 2 - - 1
34 6 7 - 3
296 91 42 35 35
10 2 2 3
11 6 1 1
13 4 - 1
52 18 10 1 1 3
8 2 - 1 2
15 7 5 5 3
72 24 13 5 6
10 2 - 3 3
40 13 7 3 .
38 12 3 2 10
5 2 1 -
22 1 1 1 4
115 29 19 35 25
7 - 1 1 3
8 4 1 - 4
26 9 1 19 5
14 3 5 5 4
3 - - 2
27 6 6 4 2
3 3 1 1 1
13 2 3 4
14 2 1 1 4
389 100 40 55 82
6 - .
14 5 - 3 4
6 - 2 1
19 4 1 - 4
25 2 3 6
124 41 20 11 18
1 - 1 1 2
4 - - 3 .
23 5 6 7
1 2 3 3
24 5 1 3 8
45 15 5 11 2
46 6 5 2 14
33 6 5 4 4
14 4 2 3 4
4 5 - 5
2,564 664 320 341 454
* Mortality data in this table are voluntarily reported from 121 cities in the United States, most of which have populations of 100,000 or 
more. A death is reported by the place of its occurrence and by the week that the death certificate was filed Fetal deaths are not 
included.
** Pneumonia and influenza
t  Because of changes in reporting methods in these 4 Pennsylvania cities, these numbers are partial counts for the current week Com­
plete counts will be available in 4 to 6 weeks, 
f t  Total includes unknown ages.
§ Data not available Figures are estimates based on average of past 4 weeks.
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(a) Dogs and Cats
All dogs and cats should be vaccinated against rabies commencing at 3 months of 
age and revaccinated in accordance with Part II of this Compendium.
(b) Livestock
It is not economically feasible, nor is it justified from a public health standpoint, to 
vaccinate all livestock against rabies. Veterinary clinicians and owners of valuable 
animals may consider immunizing certain breeding stock located in areas where 
wildlife rabies is epizootic.
(c) Other Animals
(1) Animals Maintained in Exhibits and in Zoological Parks
Captive animals not completely excluded from all contact with local vectors of 
rabies can become infected with rabies. Moreover, such animals may be incubat­
ing rabies when captured. Exhibit animals, especially those carnivores and omni­
vores having contact with the viewing public, should be quarantined for a mini­
mum of 180 days. Since no rabies vaccine is licensed for use in wild animals, vac­
cination even with inactivated vaccine is not recommended. Pre-exposure rabies 
immunization of animal workers at such facilities is recommended and reduces 
the need for euthanasia of valuable animals for rabies testing after they have 
bitten a handler.
(2) Wild Animals
Because of the existing risk of rabies among wild animals such as raccoons, 
skunks, and foxes, the American Veterinary Medical Association (AVMA), the 
NASPHV, and the Conference of State and Territorial Epidemiologists strongly 
recommend the enactment of state laws prohibiting the interstate and intrastate 
importation, distribution, and relocation of wild animals. Further, these same or­
ganizations continue to recommend the enactment of laws prohibiting the distri­
bution and/or ownership of wild animals as pets.
2. Stray Animal Control
Stray animals should be removed from the community, especially in rabies epizootic
areas. Local health department and dog control officials can enforce the pick-up of
strays more efficiently if owned animals are confined or leashed when not confined.
Strays should be impounded for at least 3 days to give owners sufficient time to reclaim
animals apprehended as strays.
3. Quarantine
(a) International: Present USDA regulations (CFR No. 71154) governing the importa­
tion of wild and domesticated felines, canines, and other potential vectors of rabies 
are minimal for preventing the introduction of rabid animals into the United States. 
All dogs and cats imported from countries with endemic rabies should be vaccinated 
against rabies at least 30 days before entry into the United States. The Centers for 
Disease Control (CDC) is responsible for these animals imported into the United 
States. CDC's requirements should be coordinated with interstate shipment 
requirements. The health authority of the state of destination should be notified 
within 72 hours of any animal conditionally admitted into its jurisdiction.
The conditional admission of such animals into the United States must be sub­
ject to state and local laws governing rabies. Failures to comply with these require­
ments should be promptly reported to the director of CDC.
(b) Interstate: Before interstate shipment, dogs and cats should be vaccinated against 
rabies according to the Compendium's recommendations and preferably shall be 
vaccinated at least 30 days before shipment. While in shipment, they should be ac­
companied by a currently valid NASPHV Form #50 , Rabies Vaccination Certificate.
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One copy of the certificate should be mailed to the appropriate public health veter­
inarian or state veterinarian of the state of destination.
(c) Health Certificates: If a certificate is required for dogs and cats in transit, it must 
not replace the NASPHV rabies vaccination certificate.
4. Adjunct Procedures
Methods or procedures that enhance rabies control include:
(a) Licensure: Registration or licensure of all dogs and cats may be used as a means of 
rabies control by controlling the stray animal population. Frequently, a fee is charged 
for such licensure and revenues collected are used to maintain a rabies or animal 
control program. Vaccination is usually recommended as a prerequisite to licensure.
(b) Canvassing of Area: This includes house-to-house calls by members of the animal 
control program to enforce vaccination and licensure requirements.
(c) Citations: These are legal summonses issued to owners for violations including the 
failure to vaccinate or license their animals.
(d) Leash Laws: All communities should adopt leash laws that can be incorporated in 
their animal control ordinances.
5. Post-Exposure Management
ANY DOMESTIC ANIMAL THAT IS BITTEN OR SCRATCHED BY A BAT OR BY A WILD, 
CARNIVOROUS MAMMAL THAT IS NOT AVAILABLE FOR TESTING SHOULD BE 
REGARDED AS HAVING BEEN EXPOSED TO A RABID ANIMAL.
(a) When bitten by a rabid animal, unvaccinated dogs and cats should be destroyed 
immediately. If the owner is unwilling to have this done, the unvaccinated animal 
should be placed in strict isolation for 6 months and vaccinated one month before 
being released. Dogs and cats that are currently vaccinated should be revaccinated 
immediately, leashed, and confined for 90  days.
(b) Livestock: All species of livestock are susceptible to rabies infection; cattle appear 
to be among the most susceptible of all domestic animal species. Livestock known 
to have been bitten by rabid animals should be destroyed (slaughtered) immediately. 
If the owner is unwilling to have this done, the animal should be kept under very 
close observation for 6 months.
Regarding the management of livestock exposed to rabid animals, the follow­
ing recommendations and considerations are suggested:
(1) If slaughtered within 7 days of being bitten, tissues may be eaten without risk of 
infection, provided liberal portions of the exposed area are discarded. Federal 
meat inspectors will reject for slaughter any animal that has been exposed to 
rabies within 8 months.
(2) No tissues or secretions from a clinically rabid animal should be used for human 
or animal consumption. However, because pasteurization temperatures will inac­
tivate rabies virus, the drinking of pasteurized milk or eating of completely 
cooked meat does not constitute a rabies exposure.
C. CONTROL METHODS IN WILD ANIMALS
1. Terrestrial Mammals
Since there is no evidence that these costly programs reduce either wildlife reservoirs 
or rabies incidence on a statewide basis, persistent, continuous, and routine trapping or 
poisoning campaigns as a means of wildlife rabies control should be abolished. 
However, limited control in high-contact areas (picnic grounds, camps, suburban areas) 
may be indicated for the removal of selected high-risk species of wild animals. The 
public should be warned not to handle wild animals. The state game department should 
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2. Bats
(a) Rabid bats have been reported from every state except Hawaii and have caused 
human rabies infections in the United States. It is neither feasible nor practical, 
however, to control rabies in bats by areawide bat population reduction programs.
(b) Bats should be eliminated from houses and surrounding structures to prevent direct 
association with people. Such structures should then be made bat-proof by sealing 
routes of entrance with screen or other means.
(c) A person bitten by a bat or any wild animal should immediately report the incident to 
a physician or hospital emergency room, which will evaluate the need for antirabies 
treatment (see current Rabies Prophylaxis Recommendation of the Public Health 
Service Immunization Practices Advisory Committee, MMWR  1982 ;31 :2 79 -80 , 
285). Bats and wild carnivorous mammals that bite people should be killed and sent 
to a laboratory for examination for rabies.
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Public Health Impact of a Snow Disaster
The severe blizzard that struck Colorado on December 24 and 25, 1982, has raised ques­
tions about the public health impact of a snow disaster. Epidemiologic studies of a similar 
storm in New England in February 1978 may help officials facing similar conditions (1-4) .
Major findings of the 1978 studies follow: 1) Although total mortality did not increase sig­
nificantly during the blizzard in eastern Massachusetts, a third (27) of all deaths were classed 
as storm related. Eight persons stranded in cars died, five from carbon monoxide intoxication. 
2) Total mortality and mortality from ischemic heart disease increased significantly in Rhode 
Island. 3) The number of emergency room visits declined 64% in Rhode Island and 56% in 
eastern Massachusetts during the blizzard but returned to normal in a few days. 4) Hospitals 
in Massachusetts had supply problems because delays in discharging patients raised oc­
cupancy rates to capacity. 5) No disease outbreaks and no water or sanitation hazards could 
be verified in eastern Massachusetts although seven were reported.
Based on this and other information, officials should consider the following recommenda­
tions during blizzards: 1) Early in the storm, warn against non-essential driving. 2) Announce 
publicly that persons who must drive should have extra clothes and food with them and 
remain in their vehicle if stranded. Advise extreme caution if the heating system is used, even 
for short periods, while the vehicle is stopped. Exhaust systems may become blocked with 
snow, and ventilation adequacy is hard to determine. 3) Establish a rumor clearinghouse to in­
vestigate reported disease outbreaks and environmental health hazards. 4) Rapidly investigate 
storm-related deaths to dispel rumors and gain data. 5) Advise hospitals that anticipate over­
crowding and supply shortages to discharge and transport patients home early, using 
emergency vehicles if necessary.
Reported by Field Svcs Div, Epidemiology Program Office, Special Swdies Br, Chronic Diseases Div, 
Center for Environmental Health, CDC.
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Influenza Update — United States
Since November 30, 1982, increasing influenza activity has been reported, including two 
nursing home outbreaks in upstate New York—one November 30-Decem ber 16 and one 
beginning December 18. In a Monroe County nursing home, about 63 (26%) of 240  residents 
experienced influenza-like illness, and six of 1 2 respiratory specimens collected grew influen­
za A(H3N2) virus. Preliminary laboratory results from the second outbreak also suggest an 
association with influenza virus; morbidity data are pending. Overall influenza-like illness in 
the region is not unusually elevated. In Idaho and Montana, however, several reports indicate 
increased influenza activity since December 20. In one small community, for example, school 
absenteeism (about 20%) caused premature closing before the winter vacation, and in several 
areas of the state physicians reported increased office visits, emergency room visits, or hospi­
tal admissions from influenza-like illness. An outbreak of influenza-like illness in an Idaho nurs­
ing home has also been reported. Although laboratory diagnosis is pending in Idaho, eight in­
fluenza A(H3N2) viruses have been isolated in Montana, including several from children with 
acute respiratory illness. In Arizona, Georgia, Hawaii, and Utah, sporadic cases of influenza 
have been confirmed by isolation of type A(H3N2) strains.
Reported by R. Betts, PhD, University of Rochester School of Medicine, New York; L Minnich, MSc, G 
Ray, MD, University of Arizona Medical School; State Laboratory Directors and State Epidemiologists; 
Field Svcs Div, Epidemiology Program Office, WHO Collaborating Center for Influenza, Influenza Br, 
Center for Infectious Diseases, CDC.
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